瓦斯:一种新的生物标志物,可以将关节关节体脂肪与2型糖尿病风险联系起来
Harry Hezhou Wang1,2, Michael Chong2,3,4,5, Nicolas Perrot2,3,4,5
1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Diabetes care
|December 6, 2023
概括
较高的血管素水平与2型糖尿病 (T2D) 的风险增加有关. 这项研究还发现,素与降低的腺骨脂肪度有关,这表明它有可能成为T2D的临床预测因子.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 遗传学 遗传学是一种遗传学.
背景情况:
- 瓦斯是一种阿迪波金,在代谢调节中具有潜在的作用.
- 了解血管,脂肪和2型糖尿病 (T2D) 之间的关系对于风险预测至关重要.
研究的目的:
- 为了调查不同的脂肪储存是否会影响瓦斯水平.
- 用流行病学和遗传学方法来确定vaspin是否可以预测T2D发展的风险.
主要方法:
- 在PURE (N=10,052) 和ORIGIN (N=7,840) 队列中,与T2D和脂肪性相关的血血管素度的流行病学分析.
- 两个样本的孟德尔随机化 (MR) 评估血管,T2D风险和遗传决定的脂肪储存之间的因果关系.
主要成果:
- 增加的素水平与发生和流行T2D的更高风险显著相关 (HR 1.16,OR 1.16).
- 较高的BMI和甘油三水平与增加的血管度相关.
- 门德尔的随机化证实了瓦斯与T2D风险的关联,并揭示了与遗传决定的关节脂的反向关系.
结论:
- 升高的血管蛋白水平与2型糖尿病的风险增加有关.
- 血管蛋白水平与关节脂肪性相反相关.
- 瓦斯作为预测T2D风险的临床生物标志物具有前景.
更多相关视频
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
8.8K
04:54Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
Published on: June 2, 2023
1.4K
相关概念视频
01:29Cholesterol: Significance and Regulation
555
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
555
01:23Dipeptidyl Peptidase 4 Inhibitors
190
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
190